November 2, 2017
Boehringer Ingelheim, Dicerna tema up to make treatments for chronic liver diseases
Boehringer Ingelheim and Dicerna Pharmaceuticals have announced a research collaboration and license agreement to discover and develop novel GalXC RNAi…